Part A: Dose Escalation of Cantrixil
NVGN-002-101
Phase 1 small_molecule completed
Quick answer
Part A: Dose Escalation of Cantrixil for Ovarian Neoplasms is a Phase 1 program (small_molecule) at KAZIA THERAPEUTICS LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- KAZIA THERAPEUTICS LTD
- Indication
- Ovarian Neoplasms
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed